Cancer Research and Nanomedicine Laboratory
Cancer Research and Nanomedicine Laboratory
Pozzi S, Scomparin A, Israeli Dangoor S, Rodriguez D, Ofek P, Neufeld L, Krivitsky A, Vaskovich-Koubi D, Kleiner R, Dey P, Koshrovski-Michael S, Reisman N, and Satchi-Fainaro R, Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? Advanced Drug Delivery Reviews, 2021 Apr 7:S0169-409X(21)00098-3. doi: 10.1016/j.addr.2021.04.001. [PDF][PubMed]
Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R, Florindo HF. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. J Control Release. 2019 Aug 10;307:108-138. [PDF] [PubMed]
Ofek P, Miller K, Eldar-Boock A, Polyak D, Segal E, Satchi-Fainaro R. Rational design of multifunctional polymer therapeutics for cancer theranostics, Special Theme issue: Polymer Therapeutics as novel nanomedicines. Israel Journal of Chemistry 2010, 50:185-203. [PDF]
Satchi-Fainaro R, Barnés CM: Drug Delivery Systems to Target the Tumour Vasculature and the Tumour Cell. TECHNOLOGY/INDUSTRY OVERVIEWS 2004(The Drug Delivery Companies Report Spring/Summer 2004):43-49. [PDF]
Copyright © 2019 Satchi-Fainaro Lab. All Rights Reserved
Designed by Galia.T